Innovations in Biotechnology and Medical Sciences

NexCAR19: India’s First Indigenous CAR T- Cell Therapy for Cancer

Note4Students

From UPSC perspective, the following things are important :

Prelims level: CAR-T Cell Therapy, NexCAR19

Mains level: NA

Why in the news?

  • President Droupadi Murmu has unveiled ‘NexCAR19’ India’s first indigenously-developed CAR T-cell therapy for cancer treatment.

What is CAR-T Cell Therapy?

What is it?
  • CAR-T cell therapy stands for Chimeric Antigen Receptor T cell therapy.
  • It is a type of cancer immunotherapy that uses the patient’s own T cells, genetically modified in a laboratory to enhance their ability to locate and destroy cancer cells.
How does it work?
  • T cells are white blood cells responsible for identifying and fighting illness and infection.
  • Each T cell has a receptor that can recognize antigens (proteins or molecules recognized by the immune system).
  • Cancer cells may have antigens that the immune system does not recognize as abnormal, allowing cancer to evade the immune response.
  • CAR-T cells are genetically engineered in the lab to express a new receptor that can bind to cancer cells and effectively kill them.
Therapy Process The process involves several steps, including:

1. Collecting T Cells: Blood is drawn from the patient’s arm, and T cells are separated from the blood using an apheresis machine.

2. Engineering T Cells: In a laboratory, the T cells are modified by adding a manufactured CAR, and they are allowed to multiply and grow.

3. Infusing CAR-T Cells: Once enough CAR-T cells are prepared, they are injected back into the patient’s arm.

  • Chemotherapy may be recommended before CAR-T cell infusion to enhance treatment effectiveness.
  • The process can take place in an outpatient infusion center or a hospital setting.
Cancers Treated
  • CAR-T cell therapy is effective against certain types of cancer, especially when other treatments are ineffective.
  • It is currently FDA-approved for treating haematological malignancies, including leukemia, lymphoma, and multiple myeloma.

 

NexCAR19: India’s Indigenously Developed CAR-T Therapy

  • NexCAR19 is designed to target cancer cells carrying the CD19 protein, a marker on cancer cells, enhancing precision in treatment.
  • It has been developed jointly by IIT Bombay and the Tata Memorial Centre.
  • Initially approved for patients aged 15 and above with B-cell lymphomas who did not respond to standard treatments, leading to relapse or recurrence.

Effectiveness and Unique Features

  • Approximately 70% of patients respond to NexCAR19 treatment, with some achieving complete remission.
  • Lab and animal studies indicate lower drug-related toxicities, including reduced neurotoxicity and Cytokine Release Syndrome (CRS).
  • Trials for paediatric patients are underway at Tata Memorial Hospital, ensuring broader applicability.

Availability and Affordability

  • ImmunoACT is in the process of securing licenses and partnering with hospitals, including Tata Memorial, Nanavati, Fortis, and Jaslok, across multiple cities.
  • Initially priced at Rs 30-40 lakh, ImmunoACT aims to eventually reduce the cost to Rs 10-20 lakh, making the therapy more accessible.

PYQ:

2017:

Stem cell therapy is gaining popularity in India to treat a wide variety of medical conditions including leukaemia, Thalassemia, damaged cornea and several burns. Describe briefly what stem cell therapy is and what advantages it has over other treatments?

 

Practice MCQ:

With reference to the CAR-T Cell Therapy, consider the following statements:

1.    T cells are Red Blood Cells responsible for identifying and fighting illness and infection.

2.    Each T cell has a receptor that can recognize antigens (proteins or molecules recognized by the immune system).

Which of the given statements is/are correct?

(a) Only 1

(b) Only 2

(c) Both 1 and 2

(d) Neither 1 nor 2

Get an IAS/IPS ranker as your 1: 1 personal mentor for UPSC 2024

Attend Now

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

JOIN THE COMMUNITY

Join us across Social Media platforms.

💥Mentorship New Batch Launch
💥Mentorship New Batch Launch